Craig J. Thomas
National Institutes of Health(US)National Cancer Institute(US)National Center for Advancing Translational Sciences(US)Center for Cancer Research(US)National Blood Clot Alliance(US)
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Computational Drug Discovery Methods, PARP inhibition in cancer therapy, Ubiquitin and proteasome pathways, Protein Degradation and Inhibitors
Most-Cited Works
- → Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma(2010)1,626 cited
- → NMDAR inhibition-independent antidepressant actions of ketamine metabolites(2016)1,565 cited
- → Pyruvate Kinase M2 Regulates Hif-1α Activity and IL-1β Induction and Is a Critical Determinant of the Warburg Effect in LPS-Activated Macrophages(2015)1,338 cited
- → Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms(2018)1,217 cited
- → Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant Responses(2011)1,171 cited
- → Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis(2012)816 cited